Amarin Corp. Plc (AMRN)
14.06
-0.50
(-3.43%)
USD |
NASDAQ |
May 18, 16:00
14.07
+0.01
(+0.07%)
Pre-Market: 20:00
Amarin Research and Development Expense (Quarterly) : 4.020M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 11.82M |
| Alkermes Plc | 101.64M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Biodexa Pharmaceuticals Plc | -- |
| Trinity Biotech Plc | 1.057M |